Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-011750
Filing Date
2025-03-10
Accepted
2025-03-10 17:11:03
Documents
1
Period of Report
2025-03-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1741641056.html 4  
1 FORM 4 wk-form4_1741641056.xml 4 3813
  Complete submission text file 0001628280-25-011750.txt   5247
Mailing Address 150 W 4TH AVENUE VANCOUVER A1 V5Y 1G6
Business Address 150 W 4TH AVENUE VANCOUVER A1 V5Y 1G6 (604) 559-9005
AbCellera Biologics Inc. (Issuer) CIK: 0001703057 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ABCELLERA BIOLOGICS INC. 150 W 4TH AVENUE VANCOUVER A1 V5Y 1G6
Business Address
Montalbano John S. (Reporting) CIK: 0001834423 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39781 | Film No.: 25724747